Gamma-secretase-independent role for cadherin-11 in neurotrophin receptor p75 (p75NTR) mediated glioblastoma cell migration

The p75 neurotrophin receptor (p75(NTR)) undergoes γ-secretase-mediated regulated intramembrane proteolysis and is involved in glioblastoma cell migration and invasion. Consistent with previous reports, in this study we show that p75NTR increases U87-MG glioblastoma cell migration, which is reversed by inhibition of γ-secretase activity. However, we show that expression or stabilization of the γ-secretase-generated p75(NTR) intracellular domain (ICD) is not sufficient to induce U87-MG glioblastoma cell migration, and that exogenous expression of p75(NTR) ICD inhibits p75(NTR)-mediated glioblastoma cell (U87-MG and U373-MG) migration. To identify pathways and to determine how p75(NTR) mediates glioblastoma migration we utilized a microarray approach to assess differential gene expression profiles between parental U87-MG and cells stably expressing wild-type p75(NTR), a γ-secretase cleavage-resistant chimeric p75(NTR) mutant (p75FasTM) and the γ-secretase-generated p75(NTR)-ICD, which mimics constitutively cleaved p75(NTR) receptor. In our microarray data analysis we identified a subset of genes that were constitutively up-regulated in wild-type p75(NTR) cells, which were also repressed in p75(NTR) ICD expressing cells. Furthermore, our data revealed among the many differentially expressed genes, cadherin-11 (Cdh-11), matrix metalloproteinase 12 and relaxin/insulin-like family peptide receptor 2 as constitutively up-regulated in wild-type p75(NTR) cells, independent of γ-secretase activity. Consistent with a role in glioblastoma migration, we found that U87-p75(NTR) cells express higher levels of Cdh-11 protein and that siRNA-mediated knockdown of Cdh-11 resulted in a significant decrease in p75(NTR)-mediated glioblastoma cell migration. Therefore, we hypothesize that p75(NTR) can impact U87-MG glioblastoma cell migration in a γ-secretase-independent manner through modulation of specific genes, including Cdh-11, and that both γ-secretase-independent and -dependent mechanisms are involved in p75(NTR)-mediated U87-MG glioblastoma cell migration.

[1]  Lei Wang,et al.  Inhibition of neurotrophin receptor p75 intramembran proteolysis by gamma-secretase inhibitor reduces medulloblastoma spinal metastasis. , 2010, Biochemical and biophysical research communications.

[2]  L. Liu,et al.  RNAi-mediated knockdown of relaxin decreases in vitro proliferation and invasiveness of osteosarcoma MG-63 cells by inhibition of MMP-9. , 2013, European review for medical and pharmacological sciences.

[3]  A. Sloan,et al.  Angiogenesis , Metastasis , and the Cellular Microenvironment Cadherin-11 , a Marker of the Mesenchymal Phenotype , Regulates Glioblastoma Cell Migration and Survival In Vivo , 2012 .

[4]  H. Yoshikawa,et al.  PKA phosphorylates the p75 receptor and regulates its localization to lipid rafts , 2003, The EMBO journal.

[5]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[6]  M. Chao,et al.  Cleavage of p75 Neurotrophin Receptor by α-Secretase and γ-Secretase Requires Specific Receptor Domains* , 2005, Journal of Biological Chemistry.

[7]  P. Barker,et al.  Ligand-Dependent Cleavage of the P75 Neurotrophin Receptor Is Necessary for NRIF Nuclear Translocation and Apoptosis in Sympathetic Neurons , 2006, Neuron.

[8]  M. Westphal,et al.  Cost of migration: invasion of malignant gliomas and implications for treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  N. Assa‐Munt,et al.  Dimerization‐dependent block of the proapoptotic effect of P75NTR , 2000, Journal of neuroscience research.

[10]  Ci Xu,et al.  Human Macrophage Metalloelastase Correlates with Angiogenesis and Prognosis of Gastric Carcinoma , 2010, Digestive Diseases and Sciences.

[11]  I. Sancho-Martinez,et al.  Yes and PI3K bind CD95 to signal invasion of glioblastoma. , 2008, Cancer cell.

[12]  Z. Korade,et al.  p75 Neurotrophin Receptor-mediated Apoptosis in Sympathetic Neurons Involves a Biphasic Activation of JNK and Up-regulation of Tumor Necrosis Factor-α-converting Enzyme/ADAM17* , 2010, The Journal of Biological Chemistry.

[13]  N. Schor,et al.  Role of tyrosine phosphorylation in the antioxidant effects of the p75 neurotrophin receptor , 2009, Oxidative medicine and cellular longevity.

[14]  James C. Powell,et al.  Association between Presenilin‐1 and TRAF6 modulates regulated intramembrane proteolysis of the p75NTR neurotrophin receptor , 2009, Journal of neurochemistry.

[15]  M. Chao,et al.  Cleavage of p75 neurotrophin receptor by alpha-secretase and gamma-secretase requires specific receptor domains. , 2005, The Journal of biological chemistry.

[16]  I. Ferrer,et al.  Pro-NGF from Alzheimer's disease and normal human brain displays distinctive abilities to induce processing and nuclear translocation of intracellular domain of p75NTR and apoptosis. , 2006, The American journal of pathology.

[17]  Manfred Westphal,et al.  The neurobiology of gliomas: from cell biology to the development of therapeutic approaches , 2011, Nature Reviews Neuroscience.

[18]  O. Bernard,et al.  Dominant-Negative c-Jun Promotes Neuronal Survival by Reducing BIM Expression and Inhibiting Mitochondrial Cytochrome c Release , 2001, Neuron.

[19]  A. M. Houghton,et al.  Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases. , 2006, Cancer research.

[20]  J. Bartek,et al.  Key concepts in glioblastoma therapy , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[21]  S. Weiss,et al.  Gamma-Secretase Represents a Therapeutic Target for the Treatment of Invasive Glioma Mediated by the p75 Neurotrophin Receptor , 2008, PLoS biology.

[22]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[23]  G. Weskamp,et al.  Evidence for a Critical Role of the Tumor Necrosis Factor α Convertase (TACE) in Ectodomain Shedding of the p75 Neurotrophin Receptor (p75NTR)* , 2004, Journal of Biological Chemistry.

[24]  V. Yong,et al.  Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12. , 2006, Cancer research.

[25]  E. Karaca,et al.  Ligand-independent signaling by disulfide-crosslinked dimers of the p75 neurotrophin receptor , 2009, Journal of Cell Science.

[26]  M. Berens,et al.  Molecular targets of glioma invasion , 2007, Cellular and Molecular Life Sciences.

[27]  Günther Richter,et al.  Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  A. Le Bivic,et al.  Role of the membrane-proximal O-glycosylation site in sorting of the human receptor for neurotrophins to the apical membrane of MDCK cells. , 2002, Experimental cell research.

[29]  L. Reichardt,et al.  Neurotrophin-regulated signalling pathways , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.

[30]  G. Gibney,et al.  p75 Neurotrophin Receptor Cleavage by α- and γ-Secretases Is Required for Neurotrophin-mediated Proliferation of Brain Tumor-initiating Cells* , 2014, The Journal of Biological Chemistry.

[31]  Shannan J. Ho Sui,et al.  oPOSSUM: integrated tools for analysis of regulatory motif over-representation , 2007, Nucleic Acids Res..

[32]  J. Peyrat,et al.  Nerve Growth Factor Stimulates Proliferation and Survival of Human Breast Cancer Cells through Two Distinct Signaling Pathways* , 2001, The Journal of Biological Chemistry.

[33]  Barbara L. Hempstead,et al.  Regulation of Cell Survival by Secreted Proneurotrophins , 2001, Science.

[34]  Y. Dong,et al.  Increased expression of human macrophage metalloelastase (MMP-12) is associated with the invasion of endometrial adenocarcinoma. , 2007, Pathology, research and practice.

[35]  R. Mrak,et al.  Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion. , 2007, Journal of experimental & clinical cancer research : CR.

[36]  Ibtissem Grissa,et al.  CRISPRFinder: a web tool to identify clustered regularly interspaced short palindromic repeats , 2007, Nucleic Acids Res..

[37]  A. Greiter-Wilke,et al.  p75 neurotrophin receptor functions as a survival receptor in brain‐metastatic melanoma cells , 2004, Journal of cellular biochemistry.

[38]  J. Wade,et al.  Human relaxin-2: historical perspectives and role in cancer biology , 2012, Amino Acids.

[39]  P. Spano,et al.  Nerve growth factor signaling in prostate health and disease , 2010, Growth factors.

[40]  Rebecca Aucoin,et al.  Brain metastases in melanoma: roles of neurotrophins. , 2004, Neuro-oncology.

[41]  P. S. Amieux,et al.  Proteolytic Processing of the p75 Neurotrophin Receptor and Two Homologs Generates C-Terminal Fragments with Signaling Capability , 2003, The Journal of Neuroscience.

[42]  A. N. Baldwin,et al.  The O-glycosylated Stalk Domain Is Required for Apical Sorting of Neurotrophin Receptors in Polarized MDCK Cells , 1997, The Journal of cell biology.

[43]  L. Trümper,et al.  Elevated Concentrations of Serum Relaxin are Associated with Metastatic Disease in Breast Cancer Patients , 2004, Breast Cancer Research and Treatment.

[44]  P. Bartlett,et al.  Palmitoylation of the C-terminal fragment of p75NTR regulates death signaling and is required for subsequent cleavage by γ-secretase , 2008, Molecular and Cellular Neuroscience.

[45]  R. McLendon,et al.  Brain Cancer Stem Cells Display Preferential Sensitivity to Akt Inhibition , 2008, Stem cells.

[46]  T. Hagemann,et al.  Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases. , 2002, Molecular human reproduction.

[47]  Charles A. Harris,et al.  BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons. , 2001, The Journal of biological chemistry.

[48]  P. McPherson,et al.  The p75NTR intracellular domain generated by neurotrophin-induced receptor cleavage potentiates Trk signaling , 2010, Journal of Cell Science.

[49]  M. Chao,et al.  Nuclear Localization of the p75 Neurotrophin Receptor Intracellular Domain*♦ , 2009, The Journal of Biological Chemistry.

[50]  Barbara L. Hempstead,et al.  Sortilin is essential for proNGF-induced neuronal cell death , 2004, Nature.

[51]  Cheng-Ping Yu,et al.  Expression of LGR8 and related biomarkers in hepatocellular carcinoma: correlation with clinicopathological parameters. , 2011, The Chinese journal of physiology.

[52]  Sung Ho Ryu,et al.  Regulated Intramembrane Proteolysis of the p75 Neurotrophin Receptor Modulates Its Association with the TrkA Receptor* , 2003, Journal of Biological Chemistry.

[53]  D. Djakiew,et al.  Neurotrophin receptor p75(NTR) suppresses growth and nerve growth factor-mediated metastasis of human prostate cancer cells. , 2002, International journal of cancer.

[54]  G. Serban,et al.  A presenilin‐1/γ‐secretase cleavage releases the E‐cadherin intracellular domain and regulates disassembly of adherens junctions , 2002, The EMBO journal.

[55]  Susumu Goto,et al.  KEGG for representation and analysis of molecular networks involving diseases and drugs , 2009, Nucleic Acids Res..

[56]  C. Creighton,et al.  Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis. , 2010, Endocrine-related cancer.

[57]  P. Barker,et al.  Trk‐dependent ADAM17 activation facilitates neurotrophin survival signaling , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  R. Black,et al.  Photic injury promotes cleavage of p75NTR by TACE and nuclear trafficking of the p75 intracellular domain , 2007, Molecular and Cellular Neuroscience.

[59]  D. Kovacs,et al.  The many substrates of presenilin/γ-secretase. , 2011, Journal of Alzheimer's disease : JAD.

[60]  Marco Domeniconi,et al.  MAG Induces Regulated Intramembrane Proteolysis of the p75 Neurotrophin Receptor to Inhibit Neurite Outgrowth , 2005, Neuron.

[61]  S. Fan,et al.  Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma. , 2011, European journal of cancer.

[62]  J. Kim,et al.  Activation of Rac GTPase by p75 Is Necessary for c-jun N-Terminal Kinase-Mediated Apoptosis , 2002, The Journal of Neuroscience.

[63]  A. Davies,et al.  p75-Mediated NF-κB Activation Enhances the Survival Response of Developing Sensory Neurons to Nerve Growth Factor , 1999, Molecular and Cellular Neuroscience.

[64]  S. Horvath,et al.  Gene Expression Profiling of Gliomas Strongly Predicts Survival , 2004, Cancer Research.

[65]  C. Greider,et al.  Comparing effects of mTR and mTERT deletion on gene expression and DNA damage response: a critical examination of telomere length maintenance-independent roles of telomerase , 2009, Nucleic acids research.

[66]  E. Germain,et al.  Overexpression of p75(NTR) increases survival of breast cancer cells through p21(waf1). , 2010, Cellular signalling.

[67]  E. Shooter,et al.  The low affinity neurotrophin receptor, p75LNTR, is palmitoylated by thioester formation through cysteine 279. , 1994, The Journal of biological chemistry.

[68]  David J. Arenillas,et al.  oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes , 2005, Nucleic acids research.

[69]  B. Hempstead,et al.  The p75 Neurotrophin Receptor Is a Central Regulator of Glioma Invasion , 2007, PLoS biology.

[70]  K. Akassoglou,et al.  Oxygen-dependent cleavage of the p75 neurotrophin receptor triggers stabilization of HIF-1α. , 2011, Molecular cell.

[71]  G. Riggins,et al.  Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells , 2009, Molecular Cancer Therapeutics.

[72]  A. Sood,et al.  The role of relaxin in endometrial cancer , 2006, Cancer biology & therapy.

[73]  R. Niedenthal,et al.  c-Cbl binds to tyrosine-phosphorylated neurotrophin receptor p75 and induces its ubiquitination. , 2004, Cellular signalling.

[74]  Hai Yan,et al.  Glioblastoma multiforme: a review of therapeutic targets , 2009, Expert opinion on therapeutic targets.

[75]  D. Djakiew,et al.  Neurotrophin receptor p75NTR suppresses growth and nerve growth factor‐mediated metastasis of human prostate cancer cells , 2002 .

[76]  Philippe P Roux,et al.  Neurotrophin signaling through the p75 neurotrophin receptor , 2002, Progress in Neurobiology.

[77]  John Quackenbush,et al.  Genesis: cluster analysis of microarray data , 2002, Bioinform..

[78]  Irving L. Weissman,et al.  Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271 , 2011, Nature.

[79]  L. Wang,et al.  Relaxin promotes in vitro tumour growth, invasion and angiogenesis of human Saos-2 osteosarcoma cells by AKT/VEGF pathway. , 2013, European review for medical and pharmacological sciences.

[80]  Philippe P Roux,et al.  The p75 Neurotrophin Receptor Activates Akt (Protein Kinase B) through a Phosphatidylinositol 3-Kinase-dependent Pathway* , 2001, The Journal of Biological Chemistry.

[81]  P. Bastiaens,et al.  Activation of the p75 Neurotrophin Receptor through Conformational Rearrangement of Disulphide-Linked Receptor Dimers , 2009, Neuron.